Effect on Ocular Survival of Adding Early Intensive Focal Treatments to a Two-Drug Chemotherapy Regimen in Patients With Retinoblastoma

Vincristine and carboplatin combined with intensive focal treatments is an effective regimen for patients with intraocular retinoblastoma. This treatment regimen has outcomes comparable to those of more toxic regimens and merits further evaluation.